US › Healthcare

Rockwell Medical Inc (RMTI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.57+4.70%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$17.3M
Revenue YoY
-8.3%
Net profit
$-1.6M
Profit YoY
-5.9%
EPS
$-0.40
EPS estimate
$-0.25
Net margin
-9.3%

EPS came in at -0.40 against a street estimate of -0.25 — a miss of 60.0%.

Key statistics

Market cap
$28.4M
Forward P/E
59.2
P/B
0.79
Book value
$9.09
EPS (TTM)
$-1.50
52-week high
$21.00
52-week low
$4.88
50-day MA
$6.56
200-day MA
$8.87
Beta
1.61

Analyst view

Analysts rate Rockwell Medical Inc a buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $30.00.

Shareholding

Insiders
15.12%
Institutions
9.87%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC3.00%
Renaissance Technologies Corp1.62%
Geode Capital Management, LLC1.09%
BlackRock Inc0.60%
Vanguard Fiduciary Trust Co0.59%
UBS Group AG0.45%
Sontag Advisory LLC0.38%
Northern Trust Corp0.26%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Rockwell Medical Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.